Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peter van Tintelen

Showing results (151-160 of 232) with videos related to

Pageof 24
Sort By:
Circulation|March 29, 2006
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathyJ Peter van Tintelen, Mark M Entius, Zahurul A Bhuiyan, et al.
Circulation|June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2018
Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathyJohanna C Herkert, Kristin M Abbott, Erwin Birnie, et al.
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
European Journal of Heart Failure|October 24, 2017
The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathyEdgar T Hoorntje, Karin Y van Spaendonck-Zwarts, Wouter P Te Rijdt, et al.
Scientific Reports|June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
International Journal of Molecular Sciences|February 25, 2023
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of <i>MYBPC3</i> Founder VariantsMark Jansen, Maike Schuldt, Beau O van Driel, et al.
European Journal of Heart Failure|November 28, 2012
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriersIngrid A W van Rijsingen, Eline A Nannenberg, Eloisa Arbustini, et al.
Scientific Reports|October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
Human Mutation|June 17, 2018
Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disordersEline Overwater, Luisa Marsili, Marieke J H Baars, et al.
Pageof 24

Showing results (151-160 of 232) with videos related to

Sort By:
Pageof 24
Circulation|March 29, 2006
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathyJ Peter van Tintelen, Mark M Entius, Zahurul A Bhuiyan, et al.
Circulation|June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2018
Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathyJohanna C Herkert, Kristin M Abbott, Erwin Birnie, et al.
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
European Journal of Heart Failure|October 24, 2017
The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathyEdgar T Hoorntje, Karin Y van Spaendonck-Zwarts, Wouter P Te Rijdt, et al.
Scientific Reports|June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
International Journal of Molecular Sciences|February 25, 2023
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of <i>MYBPC3</i> Founder VariantsMark Jansen, Maike Schuldt, Beau O van Driel, et al.
European Journal of Heart Failure|November 28, 2012
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriersIngrid A W van Rijsingen, Eline A Nannenberg, Eloisa Arbustini, et al.
Scientific Reports|October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
Human Mutation|June 17, 2018
Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disordersEline Overwater, Luisa Marsili, Marieke J H Baars, et al.
Pageof 24